RTI Surgical Completes Acquisition of Paradigm Spine

UF startup RTI Surgical has announced it has completed the acquisition of Paradigm Spine.

Paradigm Spine’s primary product is the Coflex interlaminar stabilisation device. According to a press release, this is a “differentiated, minimally invasive motion preserving stabilisation implant that is FDA PMA-approved for the treatment of moderate to severe lumbar spinal stenosis (LSS) in conjunction with decompression.”

“[The acquisition of Paradigm] marks the second completed acquisition for RTI’s spine portfolio since the second half of 2017 when we initiated a strategic transformation to reduce complexity, drive operational excellence and accelerate growth for RTI,” said Camille Farhat, president and CEO, RTI Surgical.

Learn more about RTI Surgical Completes Acquisition of Paradigm Spine.